Transform Drug Development with AI-Powered Clinical Evidence.
Access comprehensive insights from clinical trial data instantly. Our AI engine automatically extracts and analyzes efficacy endpoints from regulatory submissions, scientific literature, and public documents—enabling faster, more confident development decisions.
Platform overview
Experience how our platform transforms clinical data into actionable insights
DiseaseXplorer
Navigate therapeutic landscapes with our indication-centric analytics dashboard. Compare endpoints, outcomes, and market dynamics at a glance.
Key Benefits
Uncover Critical Insights in Minutes, Not Months
Built for industry leaders
Enterprise-grade technology
Advanced AI Architecture
Fine-tuned language models for clinical data
Proprietary trial endpoint recognition
Comprehensive quality control and validation systems
Real-time updates from new clinical trial data
Data Security & Compliance
Data encryption
Secure cloud infrastructure
Role-based access controls
Complete audit trails
Pricing
No long-term commitments. Simple monthly subscription. Instant access. Cancel anytime.
Basic
Try Trialo for free- no credit card required
Data scope
Approved branded drugs
US-only
1 disease indication
Features:
Full DiseaseXplorer access
Drug analytics
Trial analytics
Structured efficacy endpoint data
Source document verification
AI research assistant
Pro
Unlock all disease indications. Available instantly
Data scope
Approved branded drugs
US-only
All disease indications
Features: (Same as Basic, but with full data scope)
Ultimate
Enterprise Pricing
Unlock full access-including global data and development-stage drugs.
Data scope
Approved and development-stage drugs
Global
All disease indications
Features: (Same as Pro, but with global & development stage data)

About Trialo
Founded by veterans in drug development and AI engineering, Trialo is transforming how the life sciences industry leverages clinical evidence. Our platform processes clinical trial data from regulatory submissions, scientific literature, and trial registries to serve global clients across pharma, biotech, investment, and research organizations.
Stay informed
Get monthly insights on drug development intelligence.